Product ID: UCMIG35D2192
Report ID:
UCMIG35D2192 |
Region:
Global |
Published Date: Upcoming |
Pages:
165
| Tables: 55 | Figures: 60
We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.
The market for Non-small Cell Lung Cancer Therapeutics was estimated to be valued at US$ XX Mn in 2021.
The Non-small Cell Lung Cancer Therapeutics Market is estimated to grow at a CAGR of XX% by 2028.
The Non-small Cell Lung Cancer Therapeutics Market is segmented on the basis of Drug, Region.
Based on region, the Non-small Cell Lung Cancer Therapeutics Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.
The key players operating in the Non-small Cell Lung Cancer Therapeutics Market are GlaxoSmithKline plc, Novartis, AstraZeneca, Eli Lilly and Company, Pfizer Inc., F. Hoffmann-La Roche Ltd..
Product ID: UCMIG35D2192